info@seagull-health.com
SeagullHealth
语言:
search

How should I use Litfulo(Ritlecitinib)?

Ritlecitinib is a medication for the treatment of alopecia areata in adolescents aged 12 years and older, as well as adults, and has been marketed in China. It is an oral drug belonging to Janus kinase inhibitors. By inhibiting specific signaling pathways, it can promote hair regeneration. When using ritlecitinib, patients should follow the guidance of physicians and take the drug according to the specified usage and dosage to ensure optimal therapeutic effects.

Usage and Dosage of Ritlecitinib

1. What examinations are required before use?

Patients with active tuberculosis are not recommended to start using ritlecitinib.

For patients with latent tuberculosis or those at high risk of tuberculosis with negative latent tuberculosis tests, prophylactic treatment for latent tuberculosis should be administered before initiating ritlecitinib.

2. Is vaccination required before use?

Update immunizations according to current immunization guidelines.

3. What is the dosage of ritlecitinib?

The recommended dosage of ritlecitinib is 50 mg, taken orally once daily, with or without food.

4. How should this drug be taken?

Swallow the capsule whole. Do not crush, split, or chew the ritlecitinib capsule.

Ritlecitinib(Litfulo)
Ritlecitinib(Litfulo)
Adolescents aged 12 years and older, as well as adult patients, with alopecia...
WeChat Scan
Free Inquiry
Related articles
Dosage of Ritlecitinib
Ritlecitinib is an innovative oral kinase inhibitor that brings a new treatment option to patients with severe alopecia areata. Its precise dosing, complex drug interactions, and guidance for spe...
共 1 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved